Nation Mar 09 Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration By Michelle Chapman, Associated Press
Health Feb 06 Hims & Hers launches Wegovy knockoff pill, drugmaker Novo Nordisk vows to sue The announcement from Hims is the latest example of the company's efforts to capitalize on obesity drugs like Wegovy, which have shown dramatic success in helping users shed pounds. By Matthew Perrone, Associated Press
Health Sep 17 FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes The Food and Drug Administration on Tuesday posted more than 100 letters to various drugmakers and online prescribing companies, including Hims & Hers, which has built a multibillion-dollar business centered around lower-cost versions of blockbuster obesity injections. By Matthew Perrone, Associated Press